Abstract
From bosentan to macitentan for pulmonary arterial hypertension and adult congenital heart disease: Further improvement?
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have